KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $2.6 billion.

  • Merck's Cash from Financing Activities rose 20878.35% to $2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 billion, marking a year-over-year decrease of 5446.71%. This contributed to the annual value of -$7.0 billion for FY2024, which is 4619.54% down from last year.
  • Latest data reveals that Merck reported Cash from Financing Activities of $2.6 billion as of Q3 2025, which was up 20878.35% from -$3.6 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Cash from Financing Activities ranged from a high of $5.2 billion in Q4 2021 and a low of -$5.8 billion during Q1 2025
  • For the 5-year period, Merck's Cash from Financing Activities averaged around -$1.3 billion, with its median value being -$2.2 billion (2023).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first soared by 31148.0% in 2023, then crashed by 39243.42% in 2025.
  • Over the past 5 years, Merck's Cash from Financing Activities (Quarter) stood at $5.2 billion in 2021, then plummeted by 129.84% to -$1.6 billion in 2022, then crashed by 44.47% to -$2.2 billion in 2023, then tumbled by 34.03% to -$3.0 billion in 2024, then soared by 187.67% to $2.6 billion in 2025.
  • Its last three reported values are $2.6 billion in Q3 2025, -$3.6 billion for Q2 2025, and -$5.8 billion during Q1 2025.